Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialisation of innovative medicines for rare neuromuscular neuromuscular and pulmonary diseases with high unmet medical need, has announced an equity financing of CHF 20
Tags :Margrit Marti
VectivBio Holding, clinical-stage biopharmaceutical company specialising in novel transformational treatments for severe rare conditions announced the acquisition of Comet Therapeutics, a biotechnology company that has been developing drugs to address previously untreatable inherited metabolic diseases.
Platinum Equity announced that it has signed a definitive agreement to acquire Solenis, a global producer of specialty chemicals used in water-intensive industries, from Clayton, Dubilier & Rice and BASF in a transaction that implies
